Alabama Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 15 (88% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 3,097
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 47.55%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 289
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 36.84%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 50.53% 62.28%
White, Hispanic/Latino Patients 3.23% 3.46%
Black/African American, Non-Hispanic/Latino Patients 37.20% 31.49%
Black/African American, Hispanic/Latino Patients 0.26% 0.00%
Asian Patients3 0.48% 0.00%
American Indian/Alaska Native Patients3 0.77% 0.69%
Native Hawaiian/Other Pacific Islander Patients3 0.29% 0.00%
Patients with More than one race3 0.90% 0.35%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.68% 0.35%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.74% 0.00%
Unreported/Refused to Report Race and Ethnicity 2.91% 1.38%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 707
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 68.57%
COVID-19 Immunization Series Completed 989
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 58.10%
COVID-19 Immunization Series Additional 306
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 59.93%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 31.12% 40.55% 38.89%
White, Hispanic/Latino Patients 3.96% 4.15% 0.98%
Black/African American, Non-Hispanic/Latino Patients 55.45% 42.97% 52.61%
Black/African American, Hispanic/Latino Patients 0.14% 0.61% 0.00%
Asian Patients3 0.28% 0.61% 0.33%
American Indian/Alaska Native Patients3 0.28% 0.30% 3.27%
Native Hawaiian/Other Pacific Islander Patients3 0.85% 0.30% 0.00%
Patients with More than one race3 1.13% 0.81% 0.33%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 5.80% 6.47% 0.65%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.42% 1.21% 0.98%
Unreported/Refused to Report Race and Ethnicity 0.57% 2.02% 1.96%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 33.33%
1 to 24 Hours 26.67%
More Than 24 Hours 40.00%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 26.67%
Vaccine confidence 53.33%
Vaccine storage capacity 6.67%
Vaccine supply 6.67%
Other 6.67%
None 13.33%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 46.67%
Average Percent of Health Center Visits Conducted Virtually 7.33%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 46.67%
Number of Mobile Van Sites 13
Number of Pop-up Clinics 6
Number of School-Based Vaccination Sites 2

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 26.67%
Refer patients to another organization that provides monoclonal antibody therapies 26.67%
None 53.33%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 26.67%
Patient awareness/education 13.33%
Staffing capacity 26.67%
Therapy administration/onsite logistics 13.33%
Other 13.33%
None 46.67%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021